US Pharma MarketingEarly-stage candidates, mid-sized companies and of course, Chinese assets, are dominating the dealmaking picture this year.
Why pharma’s record-setting M&A streak is so unique
Why pharma’s record-setting M&A streak is so unique is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice